Insmed Incorporated (INSM)
NASDAQ: INSM · IEX Real-Time Price · USD
25.10
+0.17 (0.68%)
May 16, 2024, 4:00 PM EDT - Market closed
Insmed Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Insmed stock have an average target of 45.29, with a low estimate of 36 and a high estimate of 55. The average target predicts an increase of 80.44% from the current stock price of 25.10.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Insmed stock from 14 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 4 | 5 | 7 |
| Buy | 6 | 6 | 5 | 5 | 7 | 7 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 9 | 9 | 12 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $48 | Strong Buy | Maintains | $48 | +91.24% | May 16, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $40 → $49 | Strong Buy | Maintains | $40 → $49 | +95.22% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +107.17% | May 14, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $35 → $36 | Strong Buy | Maintains | $35 → $36 | +43.43% | May 13, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $40 → $43 | Buy | Maintains | $40 → $43 | +71.31% | May 10, 2024 |
Financial Forecast
Revenue This Year
363.12M
from 305.21M
Increased by 18.97%
Revenue Next Year
526.78M
from 363.12M
Increased by 45.07%
EPS This Year
-4.69
from -5.34
EPS Next Year
-3.88
from -4.69
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 396.1M | 645.8M | 1.3B | 2.3B | 3.4B |
| Avg | 363.1M | 526.8M | 852.0M | 1.4B | 1.9B |
| Low | 336.8M | 414.5M | 570.4M | 727.2M | 879.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 29.8% | 77.8% | 143.0% | 172.2% | 147.7% |
| Avg | 19.0% | 45.1% | 61.7% | 59.9% | 39.6% |
| Low | 10.4% | 14.2% | 8.3% | -14.7% | -35.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.90 | -3.01 | -1.53 | 0.66 | 2.91 |
| Avg | -4.69 | -3.88 | -2.35 | -1.13 | 0.27 |
| Low | -5.15 | -5.46 | -3.49 | -3.21 | -1.68 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.